By Daniella Parra Agendia said its FLEX Study has enrolled over 17,000 early-stage breast cancer patients from diverse ethnic and racial backgrounds, aiming to address racial and ethnic disparities in breast cancer treatment. The study is a large-scale, real-world evidence,...

By Karen Roman Kineticos Life Sciences said it has partnered with Orthobond, a biotechnology company focused on medical devices, through investment from the Kineticos AMR Accelerator Fund I. Kineticos strategic advisor Steve Favaloro will be joining Orthobond’s Board of Directors,...

By Daniella Parra Creyon Bio has added two prominent venture capitalists, Serge Messerlian from DCVC Bio and Shaquille Vayda from Lux Capital, to its Board of Directors, it said. The company said Messerlian has a background in hematology, oncology, and...

By Karen Roman Agilent Technologies, Inc. (NYSE: A) said it opened Biopharma CDx Services Lab in Carpinteria, California. The laboratory will contribute to drug development, therapeutics and precision medicine, as well as early clinical studies through regulatory approval, it said...

By Karen Roman Biotechnology company Medera Inc. said it entered a definitive merger agreement with Keen Vision Acquisition Corp. (Nasdaq: KVAC), with the combined company having an implied initial enterprise value of approximately $622.6 million. The transaction will close in...

By Daniella Parra Creyon Bio has received a U.S. patent for its AI-driven platform that designs safer and more effective oligonucleotide-based medicines (OBMs), it said. This company said the platform’s success includes advancing a program from concept to patient treatment...

By Karen Roman MOBILion Systems, Inc. said it appointed Rohit Khanna, Ph.D., to serve on its Board of Directors. Dr. Khanna is a life sciences executive with over three decades of experience in the analytical instrumentation industry, the company said in...

By Karen Roman Private skincare company Crown Laboratories, Inc. and biotechnology company Revance Therapeutics, Inc. (NASDAQ: RVNC), made public their merger agreement to become a new combined company. Crown plans to acquire all outstanding shares of Revance’s common stock for...

By Daniella Parra ActivePure Medical said a study showed its air decontamination system significantly reduces healthcare-associated infections and was published in the American Journal of Infection Control. The study showed a 96-99% reduction in methicillin-resistant Staphylococcus aureus (MRSA) and a...

By Karen Roman Edgewell Personal Care Co. (NYSE: EPC) updated its full year outlook to an adjusted EBITDA of approximately $356 million, compared with a previous range of $348 to $360 million. The maker of Schick brand razors said third...